Verrica Pharmaceuticals (VRCA)CFO bought ~$15K

~$15K

Approx. value · 3,536 sh @ $4.24

8,962

Holds after · shares reported

Traded

Nov 25, 2025

Filed

Nov 26, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Nov 14, 2025Company filing · Form 8-K · ResultsReported its results
2. Nov 23, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
3. Nov 25, 2025 · this disclosureInsider · 5 insiders in a week, 3rd time since 2018CFO purchased ~$15K of VRCA shares in the open market

What came next

1. Nov 25, 2025Insider · 4 peopleInsiders: 5 purchases (~$18.0M)
2. Dec 23, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 26, 2025, the Board of Directors (the “ Board ”) of Verrica Pharmaceuticals Inc. (the “ Company ”) appointed Charles Frantzreb to serve as a director of the Company effective immediately.”
3. Mar 11, 2026Company filing · Form 8-K · ResultsReported its results

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Verrica Pharmaceuticals

For Verrica Pharmaceuticals, OQRO holds 6 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VRCA page.

Other recent filings by John J. Kirby, Interim CFO

• SEC Form 4 at Verrica Pharmaceuticals (VRCA)Aug 18, 2026

The full history of John J. Kirby, Interim CFO is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Verrica Pharmaceuticals

• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026
• SEC Form 4Aug 18, 2026

Everything OQRO holds on this company is on its VRCA page.